Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.
Identifieur interne : 001114 ( PubMed/Curation ); précédent : 001113; suivant : 001115Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.
Auteurs : Timothy M. Uyeki ; Karl J. Erlandson ; George Korch ; Michael O'Hara ; Michael Wathen ; Jean Hu-Primmer ; Sally Hojvat ; Erik J. Stemmy ; Armen DonabedianSource :
- Emerging infectious diseases [ 1080-6059 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Vaccins antiviraux.
- médecine vétérinaire : Infections à coronavirus.
- virologie : Infections à coronavirus.
- Animaux, Chameaux, Coronavirus du syndrome respiratoire du Moyen-Orient, Humains, Infections à coronavirus, Modèles animaux de maladie humaine.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Viral Vaccines.
- prevention & control : Coronavirus Infections.
- veterinary : Coronavirus Infections.
- virology : Coronavirus Infections.
- Animals, Camelus, Disease Models, Animal, Humans, Middle East Respiratory Syndrome Coronavirus.
Abstract
Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.
DOI: 10.3201/eid2207.160022
PubMed: 27191188
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001114
Links to Exploration step
pubmed:27191188Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.</title><author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name></author><author><name sortKey="Erlandson, Karl J" sort="Erlandson, Karl J" uniqKey="Erlandson K" first="Karl J" last="Erlandson">Karl J. Erlandson</name></author><author><name sortKey="Korch, George" sort="Korch, George" uniqKey="Korch G" first="George" last="Korch">George Korch</name></author><author><name sortKey="O Hara, Michael" sort="O Hara, Michael" uniqKey="O Hara M" first="Michael" last="O'Hara">Michael O'Hara</name></author><author><name sortKey="Wathen, Michael" sort="Wathen, Michael" uniqKey="Wathen M" first="Michael" last="Wathen">Michael Wathen</name></author><author><name sortKey="Hu Primmer, Jean" sort="Hu Primmer, Jean" uniqKey="Hu Primmer J" first="Jean" last="Hu-Primmer">Jean Hu-Primmer</name></author><author><name sortKey="Hojvat, Sally" sort="Hojvat, Sally" uniqKey="Hojvat S" first="Sally" last="Hojvat">Sally Hojvat</name></author><author><name sortKey="Stemmy, Erik J" sort="Stemmy, Erik J" uniqKey="Stemmy E" first="Erik J" last="Stemmy">Erik J. Stemmy</name></author><author><name sortKey="Donabedian, Armen" sort="Donabedian, Armen" uniqKey="Donabedian A" first="Armen" last="Donabedian">Armen Donabedian</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27191188</idno><idno type="pmid">27191188</idno><idno type="doi">10.3201/eid2207.160022</idno><idno type="wicri:Area/PubMed/Corpus">001114</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001114</idno><idno type="wicri:Area/PubMed/Curation">001114</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001114</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.</title><author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name></author><author><name sortKey="Erlandson, Karl J" sort="Erlandson, Karl J" uniqKey="Erlandson K" first="Karl J" last="Erlandson">Karl J. Erlandson</name></author><author><name sortKey="Korch, George" sort="Korch, George" uniqKey="Korch G" first="George" last="Korch">George Korch</name></author><author><name sortKey="O Hara, Michael" sort="O Hara, Michael" uniqKey="O Hara M" first="Michael" last="O'Hara">Michael O'Hara</name></author><author><name sortKey="Wathen, Michael" sort="Wathen, Michael" uniqKey="Wathen M" first="Michael" last="Wathen">Michael Wathen</name></author><author><name sortKey="Hu Primmer, Jean" sort="Hu Primmer, Jean" uniqKey="Hu Primmer J" first="Jean" last="Hu-Primmer">Jean Hu-Primmer</name></author><author><name sortKey="Hojvat, Sally" sort="Hojvat, Sally" uniqKey="Hojvat S" first="Sally" last="Hojvat">Sally Hojvat</name></author><author><name sortKey="Stemmy, Erik J" sort="Stemmy, Erik J" uniqKey="Stemmy E" first="Erik J" last="Stemmy">Erik J. Stemmy</name></author><author><name sortKey="Donabedian, Armen" sort="Donabedian, Armen" uniqKey="Donabedian A" first="Armen" last="Donabedian">Armen Donabedian</name></author></analytic><series><title level="j">Emerging infectious diseases</title><idno type="eISSN">1080-6059</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Camelus</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (veterinary)</term><term>Coronavirus Infections (virology)</term><term>Disease Models, Animal</term><term>Humans</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Viral Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Chameaux</term><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Humains</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (médecine vétérinaire)</term><term>Infections à coronavirus (virologie)</term><term>Modèles animaux de maladie humaine</term><term>Vaccins antiviraux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Camelus</term><term>Disease Models, Animal</term><term>Humans</term><term>Middle East Respiratory Syndrome Coronavirus</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Chameaux</term><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Humains</term><term>Infections à coronavirus</term><term>Modèles animaux de maladie humaine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27191188</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7</Issue><PubDate><Year>2016</Year><Month>07</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2207.160022</ELocationID><Abstract><AbstractText>Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uyeki</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Erlandson</LastName><ForeName>Karl J</ForeName><Initials>KJ</Initials></Author><Author ValidYN="Y"><LastName>Korch</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wathen</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hu-Primmer</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hojvat</LastName><ForeName>Sally</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Stemmy</LastName><ForeName>Erik J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Donabedian</LastName><ForeName>Armen</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002162" MajorTopicYN="N">Camelus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065207" MajorTopicYN="Y">Middle East Respiratory Syndrome Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">MERS-CoV</Keyword><Keyword MajorTopicYN="Y">Middle East respiratory syndrome coronavirus</Keyword><Keyword MajorTopicYN="Y">animal models</Keyword><Keyword MajorTopicYN="Y">antibodies</Keyword><Keyword MajorTopicYN="Y">antivirals</Keyword><Keyword MajorTopicYN="Y">diagnostics</Keyword><Keyword MajorTopicYN="Y">medical countermeasures</Keyword><Keyword MajorTopicYN="Y">monoclonal</Keyword><Keyword MajorTopicYN="Y">non-human primates</Keyword><Keyword MajorTopicYN="Y">nonhuman primates</Keyword><Keyword MajorTopicYN="Y">polyclonal</Keyword><Keyword MajorTopicYN="Y">respiratory infections</Keyword><Keyword MajorTopicYN="Y">therapeutics</Keyword><Keyword MajorTopicYN="Y">vaccines</Keyword><Keyword MajorTopicYN="Y">viruses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27191188</ArticleId><ArticleId IdType="doi">10.3201/eid2207.160022</ArticleId><ArticleId IdType="pmc">PMC4918159</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Infect Dis. 2014 Dec;29:301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25303830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2014 Jun;88(12):7045-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24719424</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24841269</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Jul;20(7):1231-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24964193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Jan;14(1):8-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24355025</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2015 Feb;17(2):142-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25456101</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Ecol Epidemiol. 2015 Jul 15;5:28305</Citation><ArticleIdList><ArticleId IdType="pubmed">26183160</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Dec;20(12 ):1999-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">25418529</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Nov;87(21):11950-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23986586</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2015 Nov;485:422-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26342468</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Mar 20;347(6228):1296-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25792306</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Chemother. 2015 Dec;47(4):252-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26788409</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2015 Aug;69:81-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26209385</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2016 Feb 17;8(326):326ra21</Citation><ArticleIdList><ArticleId IdType="pubmed">26888429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2013 Oct;19(10 ):1313-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24013700</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2016 Mar;186(3):652-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26857507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2014 Apr 30;6(234):234ra59</Citation><ArticleIdList><ArticleId IdType="pubmed">24778414</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1129-31</Citation><ArticleIdList><ArticleId IdType="pubmed">27070501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Apr 1;209(7):995-1006</Citation><ArticleIdList><ArticleId IdType="pubmed">24253287</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2018-26</Citation><ArticleIdList><ArticleId IdType="pubmed">24778221</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Feb 26;372(9):846-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25714162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Aug 19;7(301):301ra132</Citation><ArticleIdList><ArticleId IdType="pubmed">26290414</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1031-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27070385</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Dec 06;17(49):null</Citation><ArticleIdList><ArticleId IdType="pubmed">23231891</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2014 May 16;63(19):431-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24827411</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 May 15;213(10):1557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Apr 17;508(7496):402-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24590073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2016 May;15(5):327-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26868298</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2015 Oct;122:28-38</Citation><ArticleIdList><ArticleId IdType="pubmed">26192750</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Dec;22(12 ):2171-2173</Citation><ArticleIdList><ArticleId IdType="pubmed">27224315</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Jul 28;6:7712</Citation><ArticleIdList><ArticleId IdType="pubmed">26218507</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2014 Jul;88(14):7796-805</Citation><ArticleIdList><ArticleId IdType="pubmed">24789777</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Dec 1;59(11):1511-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25100864</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Mar 15;213(6):904-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26203058</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24841273</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603</Citation><ArticleIdList><ArticleId IdType="pubmed">24062443</ArticleId></ArticleIdList></Reference><Reference><Citation>MBio. 2013 Sep 10;4(5):e00650-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24023385</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Sep;3(9):e343</Citation><ArticleIdList><ArticleId IdType="pubmed">16968120</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4894-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24841268</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2015 Dec 15;212(12):1904-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26198719</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Aug;89(16):8651-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26018172</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Virol. 2015 Aug;13:123-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26184451</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2015 Jul;21(7):1153-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26079346</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2016 Mar 15;62(6):755-60</Citation><ArticleIdList><ArticleId IdType="pubmed">26679623</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2015 Dec 15;212(12 ):1894-903</Citation><ArticleIdList><ArticleId IdType="pubmed">26164863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Nov;14 (11):1090-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25278221</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation><ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Pathol. 2016 May;53(3):521-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26869154</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Nov;87(21):11955-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23986593</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43</Citation><ArticleIdList><ArticleId IdType="pubmed">26124093</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Apr;89(7):3659-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25589660</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1071-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27070733</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2014 Aug 21;10(8):e1004250</Citation><ArticleIdList><ArticleId IdType="pubmed">25144235</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Biotechnol J. 2015 Oct;13(8):1078-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26242703</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Jan;22(1):49-55</Citation><ArticleIdList><ArticleId IdType="pubmed">26692185</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Jan 1;351(6268):77-81</Citation><ArticleIdList><ArticleId IdType="pubmed">26678878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Immunol. 2016 Mar;13(2):180-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25640653</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Dec;87(24):13892-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24067970</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2014 Mar;20:42-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24406736</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Oct 14;32(45):5975-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25192975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2014 Mar 18;160(6):389-97</Citation><ArticleIdList><ArticleId IdType="pubmed">24474051</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(4):e35421</Citation><ArticleIdList><ArticleId IdType="pubmed">22536382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23891402</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24599590</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2014 Dec;29:307-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25448335</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2016 Mar;490:49-58</Citation><ArticleIdList><ArticleId IdType="pubmed">26828465</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10473-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26216974</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001114 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001114 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27191188
|texte= Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27191188" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |